1054 related articles for article (PubMed ID: 33945007)
1. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC
Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review.
Arredondo J; Pastor E; Simó V; Beltrán M; Castañón C; Magdaleno MC; Matanza I; Notarnicola M; Ielpo B
Tech Coloproctol; 2020 Oct; 24(10):1001-1015. PubMed ID: 32666362
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis.
Zeng W; Liu Y; Wang C; Yang C; Lin S; Li W
Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363462
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the oncological safety of neoadjuvant chemotherapy in locally advanced colon carcinoma: a systematic review and meta-analysis of randomised clinical trials and propensity-matched studies.
Davey MG; Amir AH; Ryan OK; Donnelly M; Donlon NE; Regan M; Meshkat B; Nugent E; Joyce M; Hogan AM
Int J Colorectal Dis; 2023 Jul; 38(1):193. PubMed ID: 37432559
[TBL] [Abstract][Full Text] [Related]
5. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evidence for the Benefits of Neoadjuvant Chemotherapy and Immunotherapy in Colon Cancer: A Concise Review.
Gupta K; Elfiky A; Patel E
Discov Med; 2023 Dec; 35(179):928-935. PubMed ID: 38058057
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
Ebata Y; Nakanishi R; Tanaka Y; Kawazoe T; Tajiri H; Zaitsu Y; Nakashima Y; Ota M; Oki E; Yoshizumi T
Anticancer Res; 2024 Mar; 44(3):1281-1287. PubMed ID: 38423645
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial.
Foxtrot Collaborative Group
Lancet Oncol; 2012 Nov; 13(11):1152-60. PubMed ID: 23017669
[TBL] [Abstract][Full Text] [Related]
11. CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial.
Liu F; Tong T; Huang D; Yuan W; Li D; Lin J; Cai S; Xu Y; Chen W; Sun Y; Zhuang J
BMJ Open; 2019 Jan; 9(1):e017637. PubMed ID: 30700474
[TBL] [Abstract][Full Text] [Related]
12. Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
Aliseda D; Arredondo J; Sánchez-Justicia C; Alvarellos A; Rodríguez J; Matos I; Rotellar F; Baixauli J; Pastor C
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38381934
[TBL] [Abstract][Full Text] [Related]
13. Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials.
Platt JR; Williams CJM; Craig Z; Cairns DA; Glasbey JC; Morton D; Seligmann J
Colorectal Dis; 2023 Mar; 25(3):357-366. PubMed ID: 36710525
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.
Huang CM; Huang MY; Ma CJ; Yeh Y-; Tsai HL; Huang CW; Huang CJ; Wang JY
Radiat Oncol; 2017 Mar; 12(1):48. PubMed ID: 28270172
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection.
Yuan Y; Xiao WW; Xie WH; Cai PQ; Wang QX; Chang H; Chen BQ; Zhou WH; Zeng ZF; Wu XJ; Liu Q; Li LR; Zhang R; Gao YH
BMC Cancer; 2021 Feb; 21(1):179. PubMed ID: 33607964
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
Hu H; Zhang J; Li Y; Wang X; Wang Z; Wang H; Kang L; Liu P; Lan P; Wu X; Zhen Y; Pei H; Huang Z; Zhang H; Chen W; Zeng Y; Lai J; Wei H; Huang X; Chen J; Chen J; Tao K; Xu Q; Peng X; Liang J; Cai G; Ding K; Ding Z; Hu M; Zhang W; Tang B; Hong C; Cao J; Huang Z; Cao W; Li F; Wang X; Wang C; Huang Y; Zhao Y; Cai Y; Ling J; Xie X; Wu Z; Shi L; Ling L; Liu H; Wang J; Huang M; Deng Y;
J Clin Oncol; 2024 Apr; ():JCO2301889. PubMed ID: 38564700
[TBL] [Abstract][Full Text] [Related]
17. A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
Ueki T; Manabe T; Inoue S; Ienaga J; Yamanaka N; Egami T; Ishikawa M; Konomi H; Ikubo A; Nagayoshi K; Nakamura M; Tanaka M
Anticancer Res; 2016 Feb; 36(2):741-7. PubMed ID: 26851033
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.
Morton D; Seymour M; Magill L; Handley K; Glasbey J; Glimelius B; Palmer A; Seligmann J; Laurberg S; Murakami K; West N; Quirke P; Gray R;
J Clin Oncol; 2023 Mar; 41(8):1541-1552. PubMed ID: 36657089
[TBL] [Abstract][Full Text] [Related]
19. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).
Karoui M; Rullier A; Piessen G; Legoux JL; Barbier E; De Chaisemartin C; Lecaille C; Bouche O; Ammarguellat H; Brunetti F; Prudhomme M; Regimbeau JM; Glehen O; Lievre A; Portier G; Hartwig J; Goujon G; Romain B; Lepage C; Taieb J;
Ann Surg; 2020 Apr; 271(4):637-645. PubMed ID: 31356278
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
